Sarcomas were the most common tumors observed in Tp53-H background mice as expected from previous reports (23, 29), and deletion of Prl2 significantly reduced the incidence of sarcomas in these mice (Fig. 2E). The gene discussed is TP53; the disease is sarcoma.